Beijing Chunlizhengda Medical Instruments : ANNOUNCEMENT ON POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

北京市春立正達醫療器械股份有限公司

Beijing Chunlizhengda Medical Instruments Co., Ltd.*

(A joint stock limited company incorporated in the People's Republic of China with limited liability)

(Stock Code: 1858)

ANNOUNCEMENT ON POLL RESULTS OF

THE EXTRAORDINARY GENERAL MEETING

References are made to the circular of Beijing Chunlizhengda Medical Instruments Co., Ltd.* (the "Company") dated 25 August 2020 (the "Circular") and the notice of the Extraordinary General Meeting dated 25 August 2020 (the "Notice"). Unless otherwise indicated, capitalized terms used in this announcement shall have the same meanings as those defined in the Circular and the Notice.

CONVENING AND ATTENDANCE OF THE MEETING

The Extraordinary General Meeting (the "Meeting") of the Company was held at 9:30 a.m., on Thursday, 10 September 2020 at No. 10 Xinmi Xi Er Road, Southern District of Tongzhou Economic Development Zone, Tongzhou District, Beijing, the PRC.

The Meeting was convened by the board of directors of the Company (the "Board") and chaired by Mr. Shi Chunbao, chairman of the Board. Voting at the Meeting was conducted by a registered poll onsite. Wuyige Certified Public Accountants LLP, the Company's auditor, was appointed by the Company as the scrutineer for the voting.

The convening of the Meeting was in compliance with the requirements of the applicable laws and regulations of the PRC, the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Listing Rules") and the articles of association of the Company.

The total number of issued Shares of the Company as at the date of the EGM was 345,852,000 Shares, of which domestic shares (the "Domestic Shares") and H Shares (the "H Shares") were 250,000,000 shares and 95,852,000 shares, respectively, which was the total number of eligible shares that entitled the Shareholders to attend and vote for or against or abstain from voting on the resolutions proposed at the Meeting.

• For identification purposes only

- 1 -

No party has stated its intention in the Circular that it would vote against any resolution or that it would abstain from voting at the Meeting.

To the best knowledge, information and belief of the directors of the Company, there was no restriction on any shareholder casting votes on any of the proposed resolution at the Meeting. There were no Shares entitling the Shareholders to attend the Meeting and abstain from voting in favor as set out in Rule 13.40 of the Listing Rules and no Shareholders were required under the Listing Rules to abstain from voting at the Meeting.

Details about the attendance of the shareholders and their authorized proxies at the Meeting are set out as follows:

Number of shareholders and authorized proxies attending the Meeting	3
Of which:	Number of holders of Domestic Shares	2
	Number of holders of H Shares	1
Total number of the voting shares held by the attendees	225,652,189
Of which:	Total number of shares held by holders of Domestic Shares	209,133,335
	Total number of shares held by holders of H Shares	16,518,854
Percentage of the total number of voting shares of the Company	65.25%
Of which:	Percentage of the shares held by holders of Domestic Shares to	83.65%
	the total number of voting shares of the Company
	Percentage of the shares held by holders of H Shares to the total	17.23%
	number of voting shares of the Company

- 2 -

POLL RESULTS OF THE EGM

The voting results in respect of the proposals at the Meeting are set out as follows:

		Number of votes & percentage of
	Ordinary resolutions	the total voting shares at the Meeting (%)
		For	Against	Abstained
1.	to consider and approve the election of	222,973,156	2,679,033	0
	Mr. Zhang Jie (張杰) as a shareholder	(98.81%)	(1.19%)	(0%)
	representative Supervisor for a term of
	three years with effect from the date of
	the EGM and the Board be and is hereby
	authorised to implement the terms of his
	service contract.
	As more than half of the votes were cast in favour of this resolution, the resolution was
	duly passed as an ordinary resolution.
2.	to consider and approve the election	223,879,739	1,772,450	0
	of Mr. Wong Tak Shing (黃德盛) as	(99.21%)	(0.79%)	(0%)
	independent non-executive Director
	and to authorize the Board to fix the
	remuneration and to enter into a service
	contract with Mr. Wong Tak Shing on
	and subject to such terms and conditions
	as the Board shall think fit and to do all
	such acts and things to give effect to
	such matters.
	As more than half of the votes were cast in favour of this resolution, the resolution was
	duly passed as an ordinary resolution.

For the full text of the proposals, please refer to the Circular of the Company dated 25 August 2020.

By order of the Board

Beijing Chunlizhengda Medical Instruments Co., Ltd.*

Shi Chunbao

Chairman

Beijing, the PRC, 10 September 2020

As at the date of this announcement, the executive Directors of the Company are Mr. Shi Chunbao, Ms. Yue Shujun and Mr. Xie Feng Bao; the non-executive Director of the Company is Mr. Wang Xin; and the independent non-executive Directors of the Company are Mr. Ge Changyin, Mr. Wong Tak Shing and Mr. Weng Jie.

• For identification purposes only

- 3 -